about
Metal-organic spheres as functional systems for guest encapsulation.Synthesis of multi-shelled ZnO hollow microspheres and their improved photocatalytic activity.Delivery of cancer therapeutics using nanotechnologyFacile Fabrication of Ultrafine Hollow Silica and Magnetic Hollow Silica Nanoparticles by a Dual-Templating Approach.One-pot synthesis of surface roughness controlled hollow silica spheres with enhanced drug loading and release profile under ambient conditions in aqueous solutions.Reverse micelle-mediated synthesis of calcium phosphate nanocarriers for controlled release of bovine serum albuminSynthesis and surface functionalization of silica nanoparticles for nanomedicineNanomedicine strategies for treatment of secondary spinal cord injury.Novel ZnO hollow-nanocarriers containing paclitaxel targeting folate-receptors in a malignant pH-microenvironment for effective monitoring and promoting breast tumor regression.Immunization of mice by hollow mesoporous silica nanoparticles as carriers of porcine circovirus type 2 ORF2 proteinDetermining the pharmacokinetics and long-term biodistribution of SiO2 nanoparticles in vivo using accelerator mass spectrometry.Nonporous Silica Nanoparticles for Nanomedicine Application.Silicon-polymer hybrid materials for drug delivery.Advantages and risks of nanotechnologies in cancer patients and occupationally exposed workers.Yolk/shell nanoparticles: classifications, synthesis, properties, and applications.FITC labeled silica nanoparticles as efficient cell tags: uptake and photostability study in endothelial cells.Effects of SiO2 nanoparticles on HFL-I activating ROS-mediated apoptosis via p53 pathway.One-pot synthesis of sustained-released doxorubicin silica nanoparticles for aptamer targeted delivery to tumor cells.pH-triggered drug-releasing magnetic nanoparticles for cancer therapy guided by molecular imaging by MRI.Templating synthesis of preloaded Doxorubicin in hollow mesoporous silica nanospheres for biomedical applications.An overview on the role of silica-based materials in vaccine development.Hollow mesoporous silica nanoparticles for intracellular delivery of fluorescent dye.Efficient entrapment of dye in hollow silica nanoparticles: direct evidence using fluorescence spectroscopy.When mesoporous silica meets the alkaline polyelectrolyte: a controllable synthesis of functional and hollow nanostructures with a porous shell.Micro- and Nanoscale Hydrogel Systems for Drug Delivery and Tissue Engineering.Mesoporous silica nanoparticles equipped with surface nanovalves for pH-controlled liberation of doxorubicin.Synthesis of porous hollow silica nanostructures using hydroxyapatite nanoparticle templates.Tuning silica particle shape at fluid interfaces.Metal Coated Colloidosomes as Carriers for an Antibiotic.Monodisperse pH-sensitive protamine hollow microspheres as carriers for drug deliverySynthesis of porous hollow silica spheres using functionalized polystyrene latex spheres as templatesEncapsulation and controlled release from core–shell nanoparticles fabricated by plasma polymerizationSynthesis and drug-loading properties of folic acid-modified superparamagnetic Fe3O4 hollow microsphere core/mesoporous SiO2 shell composite particlesSynergy effects of magnetic silica nanostructures for drug delivery applicationsMetal–organic frameworks as scaffolds for the encapsulation of active species: state of the art and future perspectives
P2860
Q30374076-3EBC2535-AA5B-4E0F-BC2C-A79FBE4F198CQ30390492-585AFD5C-7A13-419D-84D7-CFA7C2EFD257Q30446963-5271E460-2CB1-4774-920F-372BEAA77DC2Q30480405-F293E3A5-8A19-4F8C-B944-739ED6ADD754Q30557235-2E092868-B19D-43E8-A4FE-1A141707578AQ33671540-ED3231B1-4244-4E87-B0F6-2BA77C412A24Q34417407-B0EC353B-7FDE-47F1-9563-BF8425D52C5FQ35063603-8FD68303-1DAD-465E-B593-F77C4E1ABB39Q35819114-C35779BA-AE5D-4515-9081-E314B2327DFCQ36235860-2D251D00-D2D0-45FA-985C-6CDF0A937967Q36402145-C6BC113A-CCB2-4BC0-9B52-4BD9075E642CQ37131939-0B7E6998-AE5C-46CF-9147-CA116AFF6B24Q37855825-7465826C-ED76-4C69-8C03-20B5365492F6Q38207696-D2B842C9-1E0C-4F14-9C27-452BE5C99923Q38633392-E0B5FA67-22C3-4AB9-98A6-CEA2B8972A02Q39466322-03F158E2-1ED8-41F6-8064-F2B470DDDB40Q39505191-152699C3-DD89-46E9-8C4F-58FC5E2738C8Q39533953-981D8615-665D-4054-8600-CED4B4E9FC5BQ39558867-04E40DCB-C6F4-4A8A-88FB-B3BEB4486C9EQ39640316-015FF730-BB9D-4AAC-AD24-78F3501063BDQ39781727-2738F0B0-1A7A-4C57-AB7B-45064E78C418Q42577213-B1EA4056-C889-4511-B6DD-9763249640DDQ44214092-AE07C7C5-77DF-4F0A-AE8F-ED6FC5818814Q44463713-3CFEAB33-7958-4AE5-BB23-0FE43E12DD37Q45860907-BCD04757-C672-4FF3-894F-6F26027D7BA8Q47144914-A802C5E8-B8BC-4809-8D84-49B9ED54ED98Q50533098-B2F803C6-F272-45CF-9470-05DC59D6B935Q51536350-FCD8AEA7-87B0-491C-9AD3-6F9D653426E0Q55410439-EEE8C2A1-B1A2-4FB4-B6A7-882026520F44Q57342050-8E294267-6517-46DB-BBDE-999301A28C6EQ57352604-241725C1-77D4-4179-AD9D-AC645AFA15A7Q57355681-B4E9634D-0847-44ED-88B1-704658652181Q57355690-6711C95B-DEC3-4758-AB8F-C5E57EF0D489Q57365190-28064606-C6FD-4323-81F6-D0B6F4ECCB7CQ57387926-010A4D14-FB37-40C4-83F4-C1D0B9CC2959
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Hollow silica nanocontainers as drug delivery vehicles.
@en
Hollow silica nanocontainers as drug delivery vehicles.
@nl
type
label
Hollow silica nanocontainers as drug delivery vehicles.
@en
Hollow silica nanocontainers as drug delivery vehicles.
@nl
prefLabel
Hollow silica nanocontainers as drug delivery vehicles.
@en
Hollow silica nanocontainers as drug delivery vehicles.
@nl
P2093
P356
P1433
P1476
Hollow silica nanocontainers as drug delivery vehicles.
@en
P2093
Ho-Geun Yoon
Jaemoon Yang
Jaewon Lee
Jin-Suck Suh
Jinyoung Kang
Kwangyeol Lee
Seungjoo Haam
Yong-Min Huh
P304
P356
10.1021/LA701688T
P407
P577
2008-03-07T00:00:00Z